case study
Standing out in a crowded ADHD treatment market
To support the launch of a first-of-its-kind ADHD patch, Mediaspace Health deployed a patient-focused digital campaign designed to build awareness and differentiate the therapy from established medications. Programmatic media and paid search helped reach high-intent audiences and accelerate prescription adoption.
The challenge
A pharmaceutical company launched a first-of-its-kind transdermal ADHD therapy into a market dominated by generic medications and well-established treatment options. The brand needed to build awareness among potential patients and clearly communicate how the therapy differed from existing treatments.
Our strategy
Mediaspace Health developed a patient-focused digital campaign that combined disease awareness with branded messaging timed to coincide with the therapy’s commercial launch. The strategy targeted adults aged 26–40 and focused on reaching individuals actively researching ADHD symptoms and treatment options.
Execution
Key campaign tactics included:
- Advertising placements on ADHD-related health websites and endemic content environments
- Programmatic media targeting ADHD patient audiences nationwide while tying patients to key HCPs at point-of-care
- Paid search campaigns capturing high-intent treatment queries
- Messaging designed to highlight the therapy’s differentiated delivery method and flexibility
Services provided
- Patient marketing strategy
- Paid search advertising
- Programmatic media buying
- Healthcare audience targeting
- Digital campaign launch strategy
Our results
Endemic site placements achieved 0.12%–0.20% CTR, double campaign benchmarks
Paid search generated 5.05% CTR
Average website engagement rate reached 62%
Prescriptions written per sales representative exceeded typical launch benchmarks
Patient prescription fills increased month-over-month during the first six months
Ready to move your next project forward?